White House News in Chinese - About (weebly.com)
German Defense Minister Annegret Kramp-Karrenbauer
NATO withdrawal from Afghanistan likely in September: German minister
Apr. 14 - NATO will likely join the United States in withdrawing all troops from Afghanistan in September, German Defence Minister Annegret Kramp-Karrenbauer said Wednesday.
"We always said: we'll go in together, we'll leave together," she told ARD public television. "I am for an orderly withdrawal and that is why I assume that we (NATO) will agree to that today."
NATO defence and foreign ministers will hold a video conference Wednesday after the US said it was planning to withdraw its forces from Afghanistan by the 20th anniversary of the September 11 suicide hijackings this year.
A US official said on Tuesday that President Joe Biden had reached the conclusion to end Washington's two-decade involvement in Afghanistan by late this year.
The US has some 2,500 troops in Afghanistan as part of a 9,600-strong NATO mission in the country.
NATO allies including Germany had been waiting for Biden to decide whether the US would stick to a May 1 deadline to withdraw under a deal struck between the administration of former US leader Donald Trump and the Taliban.
Kramp-Karrenbauer said it was now important "for us in NATO to synchronise our planning with the US planning". She did not give a precise date when German troops would withdrawal from the strife-racked country. source from
NATO withdrawal from Afghanistan likely in September: German minister
- "We always said: we'll go in together, we'll leave together," German Defence Minister Annegret Kramp-Karrenbauer told a local television.
Apr. 14 - NATO will likely join the United States in withdrawing all troops from Afghanistan in September, German Defence Minister Annegret Kramp-Karrenbauer said Wednesday.
"We always said: we'll go in together, we'll leave together," she told ARD public television. "I am for an orderly withdrawal and that is why I assume that we (NATO) will agree to that today."
NATO defence and foreign ministers will hold a video conference Wednesday after the US said it was planning to withdraw its forces from Afghanistan by the 20th anniversary of the September 11 suicide hijackings this year.
A US official said on Tuesday that President Joe Biden had reached the conclusion to end Washington's two-decade involvement in Afghanistan by late this year.
The US has some 2,500 troops in Afghanistan as part of a 9,600-strong NATO mission in the country.
NATO allies including Germany had been waiting for Biden to decide whether the US would stick to a May 1 deadline to withdraw under a deal struck between the administration of former US leader Donald Trump and the Taliban.
Kramp-Karrenbauer said it was now important "for us in NATO to synchronise our planning with the US planning". She did not give a precise date when German troops would withdrawal from the strife-racked country. source from
APRIL 13, 2021
White House Daily Briefing
Infectious disease expert Dr. Anthony Fauci and COVID-19 Response Coordinator Jeff Zients joined the White House briefing after the CDC and FDA recommended pausing the use of the Johnson & Johnson vaccine due to concerns over blood clotting. Mr. Zients said the pause “will not have a significant impact on our vaccination program.” He went on to say the administration had purchased enough Pfizer and Moderna vaccines to hit target vaccination goals. Dr. Fauci stressed the rarity of the blood clots and urged people who had been recently vaccinated to not get anxious. He said the CDC and FDA were not taking a drastic step by pausing the vaccine, rather it should give the public confidence that the FDA focused on safety.
White House Daily Briefing
Infectious disease expert Dr. Anthony Fauci and COVID-19 Response Coordinator Jeff Zients joined the White House briefing after the CDC and FDA recommended pausing the use of the Johnson & Johnson vaccine due to concerns over blood clotting. Mr. Zients said the pause “will not have a significant impact on our vaccination program.” He went on to say the administration had purchased enough Pfizer and Moderna vaccines to hit target vaccination goals. Dr. Fauci stressed the rarity of the blood clots and urged people who had been recently vaccinated to not get anxious. He said the CDC and FDA were not taking a drastic step by pausing the vaccine, rather it should give the public confidence that the FDA focused on safety.
APRIL 13, 2021
FDA and CDC Teleconference on Johnson & Johnson COVID-19 vaccine
The Centers for Disease Control and Prevention and the Food and Drug Administration held a joint teleconference on the call for a pause in the use of Johnson & Johnson’s COVID-19 vaccine while they review cases of rare blood clots in people receiving the shots. Acting FDA Commissioner Dr. Janet Woodcock begins.
FDA and CDC Teleconference on Johnson & Johnson COVID-19 vaccine
The Centers for Disease Control and Prevention and the Food and Drug Administration held a joint teleconference on the call for a pause in the use of Johnson & Johnson’s COVID-19 vaccine while they review cases of rare blood clots in people receiving the shots. Acting FDA Commissioner Dr. Janet Woodcock begins.
The Johnson & Johnson vaccine was cleared for usetn in the US in February
Johnson & Johnson vaccine paused over rare blood clots
The US, South Africa and European Union will temporarily stop the rollout of the Johnson & Johnson (J&J) Covid jab, after reports of rare blood clotting.
Apr. 14 - Six cases were detected in more than 6.8 million doses of the vaccine, the US Food and Drug Administration (FDA) said.
Johnson & Johnson has paused its EU rollout, which started this week.
It follows similar cases after doses of the AstraZeneca vaccine, which prompted curbs to its use.
The FDA said it was recommending the temporary pause "out of an abundance of caution". It confirmed that one patient died from blood clotting complications, and another is in a critical condition.
All six cases were in women aged between 18 and 48, with symptoms appearing six to 13 days after vaccination.
Following the advice, all federal sites in the US have stopped using the vaccine until further investigations into its safety are completed. State and private contractors are expected to follow suit.
The US has by far the most confirmed cases of Covid-19 - more than 31 million - with more than 562,000 deaths, another world high. continue to read
Related Articles:
Johnson & Johnson vaccine paused over rare blood clots
The US, South Africa and European Union will temporarily stop the rollout of the Johnson & Johnson (J&J) Covid jab, after reports of rare blood clotting.
Apr. 14 - Six cases were detected in more than 6.8 million doses of the vaccine, the US Food and Drug Administration (FDA) said.
Johnson & Johnson has paused its EU rollout, which started this week.
It follows similar cases after doses of the AstraZeneca vaccine, which prompted curbs to its use.
The FDA said it was recommending the temporary pause "out of an abundance of caution". It confirmed that one patient died from blood clotting complications, and another is in a critical condition.
All six cases were in women aged between 18 and 48, with symptoms appearing six to 13 days after vaccination.
Following the advice, all federal sites in the US have stopped using the vaccine until further investigations into its safety are completed. State and private contractors are expected to follow suit.
The US has by far the most confirmed cases of Covid-19 - more than 31 million - with more than 562,000 deaths, another world high. continue to read
Related Articles:
APRIL 13, 2021
President Biden Meets with Congressional Black Caucus
President Biden met with the Congressional Black Caucus at the White House. He also addressed the CDC and FDA recommendation to pause the use of the Johnson & Johnson COVID-19 vaccine, saying the country has enough supply without it.
President Biden Meets with Congressional Black Caucus
President Biden met with the Congressional Black Caucus at the White House. He also addressed the CDC and FDA recommendation to pause the use of the Johnson & Johnson COVID-19 vaccine, saying the country has enough supply without it.
